Pages that link to "Q24323326"
Jump to navigation
Jump to search
The following pages link to Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein (Q24323326):
Displaying 50 items.
- Angiomotin (Q4763281) (← links)
- Angiomotin-like 1 (Q21981186) (← links)
- PTPN14 is required for the density-dependent control of YAP1 (Q24297998) (← links)
- Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions (Q24307997) (← links)
- Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1 (Q24316087) (← links)
- PTPN14 interacts with and negatively regulates the oncogenic function of YAP (Q24316475) (← links)
- Structures of YAP protein domains reveal promising targets for development of new cancer drugs (Q24612471) (← links)
- α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1 (Q24613385) (← links)
- Mechanoregulation of Wound Healing and Skin Homeostasis (Q26740308) (← links)
- YAP-Mediated Mechanotransduction in Skeletal Muscle (Q26766774) (← links)
- Emerging role of Hippo pathway in gastric and other gastrointestinal cancers (Q26774473) (← links)
- Cadherin signaling: keeping cells in touch (Q26784615) (← links)
- MST kinases in development and disease (Q26787040) (← links)
- Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. (Q26827810) (← links)
- Mammalian Hippo signalling: a kinase network regulated by protein-protein interactions (Q26849472) (← links)
- Harnessing Hippo in the heart: Hippo/Yap signaling and applications to heart regeneration and rejuvenation (Q26995264) (← links)
- The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment (Q27025661) (← links)
- Functional role of Mst1/Mst2 in embryonic stem cell differentiation (Q27302367) (← links)
- Atypical protein kinase C induces cell transformation by disrupting Hippo/Yap signaling (Q27305890) (← links)
- FOXC2 and fluid shear stress stabilize postnatal lymphatic vasculature (Q27332286) (← links)
- Constitutive expression of Yes-associated protein (Yap) in adult skeletal muscle fibres induces muscle atrophy and myopathy (Q27333208) (← links)
- Targeting Mechanotransduction at the Transcriptional Level: YAP and BRD4 Are Novel Therapeutic Targets for the Reversal of Liver Fibrosis (Q28070012) (← links)
- Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy (Q28078129) (← links)
- YAP and TAZ: a nexus for Hippo signaling and beyond (Q28085636) (← links)
- Emerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancer (Q28086905) (← links)
- Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP (Q28241192) (← links)
- Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators (Q28504464) (← links)
- Regulation of localization and function of the transcriptional co-activator YAP by angiomotin. (Q30352874) (← links)
- Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers. (Q30354662) (← links)
- The Hippo-YAP signaling pathway and contact inhibition of growth (Q30408095) (← links)
- The Hippo signaling pathway in stem cell biology and cancer (Q30410176) (← links)
- Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1 (Q30417692) (← links)
- What do mechanotransduction, Hippo, Wnt, and TGFβ have in common? YAP and TAZ as key orchestrating molecules in ocular health and disease (Q30429628) (← links)
- Angiomotins link F-actin architecture to Hippo pathway signaling (Q33604410) (← links)
- Crumbs promotes expanded recognition and degradation by the SCF(Slimb/β-TrCP) ubiquitin ligase (Q33627336) (← links)
- Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry. (Q33819083) (← links)
- Angiomotin Family Members: Oncogenes or Tumor Suppressors? (Q33837277) (← links)
- Age-related dysfunction in mechanotransduction impairs differentiation of human mammary epithelial progenitors (Q34004237) (← links)
- PP1A-mediated dephosphorylation positively regulates YAP2 activity (Q34016621) (← links)
- ZO proteins redundantly regulate the transcription factor DbpA/ZONAB (Q34070506) (← links)
- Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells (Q34187277) (← links)
- Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP. (Q34191953) (← links)
- Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor (Q34207272) (← links)
- The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis (Q34246027) (← links)
- YAP1 recruits c-Abl to protect angiomotin-like 1 from Nedd4-mediated degradation (Q34256700) (← links)
- Polarity-dependent distribution of angiomotin localizes Hippo signaling in preimplantation embryos. (Q34352631) (← links)
- Phosphorylation of angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration, and angiogenesis (Q34376255) (← links)
- The role of angiomotin phosphorylation in the Hippo pathway during preimplantation mouse development. (Q34420716) (← links)
- Energy stress regulates hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein (Q34469155) (← links)
- The hippo pathway in heart development, regeneration, and diseases (Q34470968) (← links)